Evidence map›Paper›PMID 42705703›Full record

ArticleBMJ open quality2026

Antenatal magnesium sulphate for neuroprotection of preterm babies: data analysis of inequities in treatment in England 2014 to 2024.

Hannah B Edwards, Lauren J Scott, Cheryl McQuire, Isobel L Ward, David Odd, Frank de Vocht, Karen Luyt

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open quality, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hannah B EdwardsPopulation Health Sciences, University of Bristol Medical School, Bristol, UK hannah.edwards@bristol.ac.uk.ORCID http://orcid.org/0000-0002-1885-4771
Lauren J ScottPopulation Health Sciences, University of Bristol Medical School, Bristol, UK.ORCID http://orcid.org/0000-0003-3129-5123
Cheryl McQuirePopulation Health Sciences, University of Bristol Medical School, Bristol, UK.
Isobel L WardPopulation Health Sciences, University of Bristol Medical School, Bristol, UK.
David OddPopulation Medicine, Cardiff University School of Medicine, Cardiff, UK.
Frank de VochtPopulation Health Sciences, University of Bristol Medical School, Bristol, UK.
Karen LuytNIHR ARC West, Bristol, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify (a) Sociodemographic differences in treatment with antenatal magnesium sulphate (MgSO4) for fetal neuroprotection in preterm birth and (b) Whether any sociodemographic differences have reduced over time, in conjunction with implementation of a national quality improvement (QI) programme to improve use of MgSO4.

designRetrospective cohort study using routinely collected data.

settingNHS England maternity units from 2014 to 2024.

participantsMothers with a preterm baby born from 24 to under 30 weeks' gestation and admitted to an NHS neonatal unit. OUTCOMES: Receipt of antenatal MgSO4.

resultsBefore implementation of the National

conclusionsPrevious sociodemographic differences in receipt of antenatal MgSO4 treatment for preterm birth appear to have equalised in England. This follows, and could be due in part to England's universal implementation of the National

Indexed as

Healthcare DisparitiesMagnesium SulfateNeuroprotectionNeuroprotective AgentsPrenatal CareAdultCohort StudiesEnglandFemaleHumansInfant, NewbornInfant, PrematurePregnancyPremature BirthRetrospective StudiesMagnesium SulfateNeuroprotective AgentsHealthcare quality improvementHealth EquityHealth services researchMaternal Health ServicesObstetrics and gynecology

Identifiers

PMID42705703
PMCPMC13561023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.